Frazier Lifesciences Acquisition (FLAC) Income Statement (2021 - 2022)
Income Statement report data from Mar 31, 2021 to Sep 30, 2022 for Frazier Lifesciences Acquisition (FLAC).
Reported currency: USD
| Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||
Selling General And Administrative | 2.29M (+15.08%) | 1.99M (+485.29%) | 340K (-24.44%) | 450K (+21.62%) | 370K (+19.35%) | 310K (+29.17%) | 240K |
Operating Expenses | 2.29M (+15.08%) | 1.99M (+485.29%) | 340K (-24.44%) | 450K (+21.62%) | 370K (+19.35%) | 310K (+29.17%) | 240K |
Operating Income | |||||||
Operating Income | -2.29M (+15.08%) | -1.99M (+485.29%) | -340.00K (-24.44%) | -450.00K (+21.62%) | -370.00K (+19.35%) | -310.00K (+29.17%) | -240.00K |
EBITDA | -2.29M (+15.08%) | -1.99M (+485.29%) | -340.00K (-24.44%) | -450.00K (+21.62%) | -370.00K (+19.35%) | -310.00K (+29.17%) | -240.00K |
Other Income / Expenses | |||||||
Interest Income | 710K (+610.00%) | 100K (+900.00%) | 10K | - | - | 10K | - |
Net Interest Income | 710K (+610.00%) | 100K (+900.00%) | 10K | - | - | 10K | - |
Other Non Operating Income | -3.19M | 720K (-58.14%) | 1.72M (+24.64%) | 1.38M (-34.29%) | 2.10M | -1.00M | 3.05M |
Net Income | |||||||
Income Before Tax | -4.78M (+308.55%) | -1.17M | 1.38M (+48.39%) | 930K (-46.24%) | 1.73M | -1.30M | 2.82M |
Net Income From Continuing Operations | -4.78M (+308.55%) | -1.17M | 1.38M (+48.39%) | 930K (-46.24%) | 1.73M | -1.30M | 2.82M |
Net Income | -4.78M (+308.55%) | -1.17M | 1.38M (+48.39%) | 930K (-46.24%) | 1.73M | -1.30M | 2.82M |